IPSEN BIOINNOVATION LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for IPSEN BIOINNOVATION LIMITED.The latest application filed is for "cationic neurotoxins".
Company Profile
30.45.33
- IPSEN BIOINNOVATION LIMITED - Abingdon GB
- IPSEN BIOINNOVATION, LIMITED - Abingdon, Oxfordshire N/A GB
- IPSEN BIOINNOVATION LTD - Oxon GB
- Ipsen Bioinnovation Ltd. - Abingdon, Oxon N/A GB
- IPSEN BIOINNOVATION LIMITED - Abingdon, Oxon N/A GB
- Ipsen BioInnovation, Ltd. - Abingdon, Oxfordshire N/A GB
- Ipsen Bioinnovation Ltd. - Abingdon CA
- IPSEN BIOINNOVATION LIMITED - Abington Oxfordshire GB
Patent Activity
| Patent | Date |
|---|---|
| Methods for the manufacture of proteolytically processed polypeptides Grant 11,441,141 - Rummel September 13, 2 | 2022-09-13 |
| Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins Grant 11,248,219 - James , et al. February 15, 2 | 2022-02-15 |
| Cationic Neurotoxins App 20210246175 - ANDERSON; Dina Brady ; et al. | 2021-08-12 |
| Cationic neurotoxins Grant 11,034,947 - Anderson , et al. June 15, 2 | 2021-06-15 |
| Evolution Of Bont Peptidases App 20210163924 - Packer; Michael S. ; et al. | 2021-06-03 |
| Cationic neurotoxins Grant 11,014,968 - Anderson , et al. May 25, 2 | 2021-05-25 |
| Carrier for targeting nerve cells Grant 10,883,096 - Rummel , et al. January 5, 2 | 2021-01-05 |
| Methods For The Manufacture Of Proteolytically Processed Polypeptides App 20200339971 - Rummel; Andreas | 2020-10-29 |
| Methods for the manufacture of proteolytically processed polypeptides Grant 10,808,236 - Rummel October 20, 2 | 2020-10-20 |
| Cationic Neurotoxins App 20200291073 - ANDERSON; Dina Brady ; et al. | 2020-09-17 |
| Method for suppressing spasmodic torticollis Grant 10,744,190 - Chaddock , et al. A | 2020-08-18 |
| Therapeutic fusion proteins Grant 10,704,038 - Chaddock , et al. | 2020-07-07 |
| Cationic neurotoxins Grant 10,647,750 - Anderson , et al. | 2020-05-12 |
| Non-cytotoxic protein conjugates Grant 10,619,146 - Foster , et al. | 2020-04-14 |
| Suppression of prostate cancer using a targeted clostridial neurotoxin Grant 10,550,377 - Madec , et al. Fe | 2020-02-04 |
| Carrier For Targeting Nerve Cells App 20200024588 - RUMMEL; Andreas ; et al. | 2020-01-23 |
| Fusion Proteins And Methods For Treating, Preventing Or Ameliorating Pain App 20190309277 - JAMES; Peter ; et al. | 2019-10-10 |
| Manufacture Of Recombinant Clostridial Botulinum Neurotoxins App 20190201505 - PALAN; Shilpa ; et al. | 2019-07-04 |
| Manufacture of di-chain recombinant Clostridium botulinum neurotoxins using Lys-C and a hydrophobic surface Grant 10,307,468 - Palan , et al. | 2019-06-04 |
| Suppression Of Cancer App 20190127718 - Madec; Frederic ; et al. | 2019-05-02 |
| Carrier for targeting nerve cells Grant 10,266,816 - Rummel , et al. | 2019-04-23 |
| Methods For The Manufacture Of Proteolytically Processed Polypeptides App 20190100739 - Rummel; Andreas | 2019-04-04 |
| Polypeptides that bind to and inhibit secretion from growth hormone secreting cells Grant 10,240,138 - Madec , et al. | 2019-03-26 |
| Therapeutic Fusion Proteins App 20190062721 - Chaddock; John ; et al. | 2019-02-28 |
| Re-targeted Toxin Conjugates App 20180362951 - Foster; Keith ; et al. | 2018-12-20 |
| Suppression of cancer Grant 10,113,159 - Madec , et al. October 30, 2 | 2018-10-30 |
| Suppression Of Itch App 20180298367 - FOSTER; KEITH | 2018-10-18 |
| Cationic Neurotoxins App 20180298366 - ANDERSON; Dina Brady ; et al. | 2018-10-18 |
| Methods for the manufacture of proteolytically processed polypeptides Grant 10,087,432 - Rummel October 2, 2 | 2018-10-02 |
| Therapeutic fusion proteins Grant 10,081,803 - Chaddock , et al. September 25, 2 | 2018-09-25 |
| Recombinant clostridium botulinum neurotoxins Grant 10,030,238 - Cossins , et al. July 24, 2 | 2018-07-24 |
| Cationic Neurotoxins App 20180141982 - ANDERSON; Dina Brady ; et al. | 2018-05-24 |
| Manufacture Of Recombinant Clostridium Botulinum Neurotoxins App 20180117128 - PALAN; SHILPA ; et al. | 2018-05-03 |
| Cationic neurotoxins Grant 9,920,310 - Anderson , et al. March 20, 2 | 2018-03-20 |
| Modified non-cytotoxic proteases Grant 9,849,163 - Chaddock , et al. December 26, 2 | 2017-12-26 |
| Fusion Proteins And Methods For Treating, Preventing Or Ameliorating Pain App 20170327810 - JAMES; Peter ; et al. | 2017-11-16 |
| Carrier For Targeting Nerve Cells App 20170275607 - Rummel; Andreas ; et al. | 2017-09-28 |
| Carrier for targeting nerve cells Grant 9,650,622 - Rummel , et al. May 16, 2 | 2017-05-16 |
| Non-cytotoxic Protein Conjugates App 20160369257 - FOSTER; Keith ; et al. | 2016-12-22 |
| Cationic Neurotoxins App 20160369256 - ANDERSON; Dina ; et al. | 2016-12-22 |
| Non-cytotoxic protein conjugates Grant 9,474,807 - Foster , et al. October 25, 2 | 2016-10-25 |
| Modified Non-cytotoxic Proteases App 20160279208 - CHADDOCK; John Andrew ; et al. | 2016-09-29 |
| Transport protein which is used to introduce chemical compounds into nerve cells Grant 9,422,344 - Rummel August 23, 2 | 2016-08-23 |
| Suppression Of Itch App 20160137999 - FOSTER; Keith | 2016-05-19 |
| Fusion proteins Grant 9,243,301 - Foster , et al. January 26, 2 | 2016-01-26 |
| Transport protein which is used to introduce chemical compounds into nerve cells Grant 9,234,011 - Rummel January 12, 2 | 2016-01-12 |
| Therapeutics For Suppressing Osteoporosis App 20150353908 - FOSTER; Keith | 2015-12-10 |
| Assay for assessment of endosomal transport Grant 9,170,252 - Harper October 27, 2 | 2015-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 